The Promise of Dendritic Cell Vaccines with Diakonos Oncology President and COO Jay Hartenbach

from Rx for Biotech · host Podcast Host Chris Leidli

In this podcast episode, hear from Diakonos Oncology President and Chief Operating Officer Jay Hartenbach, who provides an update on the company's innovative dendritic cell vaccine therapy designed to tackle some of the most challenging cancers, including glioblastoma and pancreatic cancer

Episode metadata supplied by the publisher feed · Published Mar 2, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

The Promise of Dendritic Cell Vaccines with Diakonos Oncology President and COO Jay Hartenbach

0:00 24:48

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Wild WinsDay Wild WinsDay Pump the hump with WILD WINSday 🐪💪: Your 3-minute weekly video boost for leadership, sales, marketing, and business breakthroughs to WIN the day!

Frequently Asked Questions

How long is this episode of Rx for Biotech?

This episode is 24 minutes long.

When was this Rx for Biotech episode published?

This episode was published on March 2, 2025.

Can I download this Rx for Biotech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!